Screener
10x Genomics, Inc. TXG Total available-for-sale securities, fair value
Total available-for-sale securities, fair value at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept txg:DebtSecuritiesAvailableForSaleIncludingMoneyMarketFunds.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30, 2026 / Amortized Cost | June 30, 2026 / Gross Unrealized Gains | June 30, 2026 / Gross Unrealized Losses | June 30, 2026 / Fair Value | December 31, 2025 / Amortized Cost | December 31, 2025 / Gross Unrealized Gains | December 31, 2025 / Gross Unrealized Losses | December 31, 2025 / Fair Value | Fair Value Measurement |
|---|---|---|---|---|---|---|---|---|---|
| Cash equivalents: | |||||||||
| Money market funds | $477,135 | — | — | $477,135 | $441,108 | — | — | $441,108 | Level 1 |
| Marketable securities: | |||||||||
| Government debt securities | 49,546 | — | (25) | 49,521 | 49,431 | 12 | — | 49,443 | Level 2 |
| Total available-for-sale securities | $526,681 | — | $(25) | $526,656 | $490,539 | $12 | — | $490,551 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s total available-for-sale securities, fair value?
- 10x Genomics, Inc. (TXG) reported total available-for-sale securities, fair value of $526.66M in Q2 2026.
- How has 10x Genomics, Inc.'s total available-for-sale securities, fair value changed year-over-year?
- 10x Genomics, Inc.'s total available-for-sale securities, fair value increased by 22.4% year-over-year, from $430.22M to $526.66M.
- What is the long-term trend for 10x Genomics, Inc.'s total available-for-sale securities, fair value?
- Over 3 years (2022 to 2025), 10x Genomics, Inc.'s total available-for-sale securities, fair value has grown at a 9.5% compound annual growth rate (CAGR), from $373.42M to $490.55M.
- What does total available-for-sale securities, fair value mean?
- Total available-for-sale securities, fair value as reported by 10x Genomics, Inc. Class A Common Stock.
Ask your AI about 10x Genomics, Inc.'s total available-for-sale securities, fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude